Cheng-Han Chen, MD, PhD, is the medical director of the structural heart program at MemorialCare Saddleback Medical Center in Laguna Hills, California, and director of structural and interventional cardiology at Pacific Cardiovascular Associates Medical Group.
Dr. Chen completed his bachelor’s and master’s degrees at MIT in materials science and engineering. He received his MD degree from UCSD and his PhD in bioengineering from UCLA.
As a medical device engineer at Medtronic, Chen played an important role in the development of the Endeavor and Resolute drug-eluting coronary stents. His internship and residency were completed at UCLA, where he also completed his cardiovascular disease fellowship. He went on to complete both interventional cardiology fellowship followed by structural heart disease fellowship at NewYork-Presbyterian/Columbia University Hospital. While at Columbia, he was closely involved in the major clinical trials involving transcatheter aortic valve replacement (TAVR).
Chen has presented his research at major national and international conferences including the American Heart Association (AHA), American College of Cardiology (ACC), and Transcatheter Cardiovascular Therapeutics (TCT), and has authored multiple manuscripts and book chapters on subjects ranging from interventional cardiology to cardiac stem cells. Prior to his current roles, he served on faculty of Columbia University Medical Center as a clinical instructor.
Outside of the office, Chen enjoys spending time with his wife and children. He is also an accomplished violinist.